ConvaTec Group PLC represents a strong set of values and a customer-centric corporate philosophy. With a focus on improving the lives of patients, ConvaTec is committed to delivering innovative medical products and solutions. They aim to provide high-quality, reliable, and advanced healthcare technologies that meet the diverse and evolving needs of individuals. By leveraging their expertise and collaborative approach, ConvaTec aims to drive positive healthcare outcomes and enhance patient experiences. With a global presence and a dedicated team, they continuously strive to make a difference in the healthcare industry, emphasizing integrity, innovation, and compassion.

ConvaTec Group PLC is primarily present in various countries and regions worldwide. As a global company, its operations span across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. With a strong international presence, ConvaTec serves customers and patients in numerous countries, including the United States, Canada, United Kingdom, Germany, France, Italy, Spain, Australia, China, Japan, and many more. By establishing a diverse and extensive geographic footprint, ConvaTec aims to provide its innovative healthcare products and solutions to a broad range of individuals, healthcare professionals, and healthcare systems around the world.

ConvaTec Group PLC has achieved several significant milestones throughout its history. Some notable achievements include the company's initial public offering (IPO) in 2016, which marked a major milestone in its growth and development. Additionally, ConvaTec has successfully introduced innovative products and solutions in the healthcare industry, such as its advanced wound care products, ostomy care solutions, and continence and critical care products. The company has also expanded its global footprint by establishing a strong presence in various geographical markets, providing healthcare solutions to a wide range of patients worldwide. ConvaTec's commitment to continuous innovation, product development, and global expansion has contributed to its success and reputation in the healthcare industry.

ConvaTec Group PLC is a well-established global medical products and technologies company. Founded in 1978, it has a rich and extensive history in the healthcare industry. ConvaTec specializes in developing and manufacturing innovative medical devices, including advanced wound care, ostomy care, continence and critical care products. With headquarters in the UK, ConvaTec operates in over 100 countries, serving healthcare professionals and patients worldwide. Over the years, ConvaTec has earned a strong reputation for its high-quality products, commitment to research and development, and dedication to improving patient lives. As a leading player in the medical industry, ConvaTec Group PLC continues to strive for excellence and innovation in healthcare solutions.

The main competitors of ConvaTec Group PLC in the market are Coloplast A/S, Medtronic plc, and Hollister Incorporated.

ConvaTec Group PLC is primarily active in the healthcare industry.

The business model of ConvaTec Group PLC revolves around providing innovative medical products and services. ConvaTec is a global medical technology company that specializes in the development, manufacturing, and distribution of products for the care of chronic conditions. Their diverse product portfolio includes advanced wound care, ostomy care, continence, and critical care products. By focusing on research, development, and collaboration with healthcare professionals, ConvaTec aims to improve the quality of life for patients worldwide. With a commitment to continuous innovation and a customer-centric approach, ConvaTec Group PLC strives to meet the evolving needs of the healthcare industry.

ConvaTec Group KGV ir 19,29.

ConvaTec Group KUV ir 2,48.

AlleAktien kvalitātes vērtējums ConvaTec Group ir 3/10.

gaidāmā ConvaTec Group apgrozījums ir 2,30 miljardi USD.

gaidāmā ConvaTec Group peļņa ir 295,31 milj. USD.

The ConvaTec Group PLC is a British company specializing in medical products and services. It offers a wide range of products in four business areas: ostomy products, continence and intimate hygiene products, wound therapeutics, and infusion and respiratory products. Ostomy Products ConvaTec offers a comprehensive range of ostomy products for people with intestinal diseases such as colon cancer, Crohn's disease, or ulcerative colitis. The products are developed in close collaboration with patients and healthcare professionals to ensure the best fit and user-friendliness. Continence and Intimate Hygiene Products ConvaTec also produces products for continence and intimate hygiene, such as diapers, pads, and skincare products. These products are designed for patients with urinary or fecal incontinence, as well as for people with limited mobility. Wound Therapeutics The wound therapeutics business area includes a wide range of products for wound care, including compression bandages, foam and hydrocolloid dressings, alginates, and silicone gels. These products are used to treat wounds such as pressure ulcers, venous leg ulcers, and surgical wounds. Infusion and Respiratory Products The infusion and respiratory products business area offers a wide range of medical products used in the treatment of lung diseases such as COPD, asthma, and pneumonia. These products include inhalers, oxygen therapy devices, and infusion devices. Additional Services ConvaTec also provides services such as training for healthcare professionals and patients. These trainings cover various areas, including stoma care, wound care, and continence management. Additionally, the company offers consulting services for healthcare professionals. Business Model ConvaTec achieves its business model by identifying needs and challenges in the healthcare industry and developing and manufacturing innovative products and services. The company works closely with healthcare professionals and patients to ensure that the products meet the users' requirements and needs. The company also focuses on a strong presence in the global market, facilitated by strategic acquisitions and partnerships. ConvaTec has offices and distribution centers in over 100 countries worldwide and employs over 9,000 people. Furthermore, ConvaTec places great emphasis on research and development and invests in the development of new products and technologies. The company collaborates closely with universities and research institutions to support its research and development activities. Overall, ConvaTec's business model is focused on developing and globally distributing innovative products and services to meet the needs of healthcare professionals and patients, thereby improving the health and well-being of millions of people.

ConvaTec Group izmaksā dividendes 0,05 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt ConvaTec Group vai uzņēmums nedod dividendes.

ConvaTec Group ISIN ir GB00BD3VFW73.

ConvaTec Group WKN ir A2AUD3.

ConvaTec Group simbols ir CTEC.L.

Pēdējo 12 mēnešu laikā ConvaTec Group maksāja dividendes 0,05 USD apmērā. Tas atbilst aptuveni 1,81 % dividendes ražībai. Nākamajos 12 mēnešos ConvaTec Group plāno maksāt dividendes 0,05 USD apmērā.

ConvaTec Group pašreizējā dividendu rentabilitāte ir 1,81 %.

ConvaTec Group maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos maijs, septembris, maijs, septembris.

ConvaTec Group pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0,05 USD. Tas atbilst dividendes ražībai 1,80 %.

ConvaTec Group tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu ConvaTec Group apmērā 0,014 USD, kas tika izmaksāta 4.10.2024., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 22.08.2024..

Pēdējās dividendes izmaksa notika 4.10.2024..

Gadā 2023, ConvaTec Group izmaksāja 0,046 USD dividendes.

ConvaTec Group dividendes tiek izmaksātas USD.